NCT06203327 Atrophic Gastritis Predicts the Risk of Gastric Cancer
| NCT ID | NCT06203327 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Shanghai Jiao Tong University School of Medicine |
| Condition | Atrophic Gastritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,042 participants |
| Start Date | 2023-12-15 |
| Primary Completion | 2034-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,042 participants in total. It began in 2023-12-15 with a primary completion date of 2034-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Despite declining incidence rates, gastric cancer (GC) ranks the fourth leading cause of cancer-related mortality and the fifth most common cancer worldwide, with the highest incidence reported in Eastern Asia. The 5-year overall survival rate of early GC exceeds 90%, which was well above advanced GC. Most intestinal-type GCs follow the Correa cascade-inflammation,atrophy, intestinal metaplasia (IM), dysplasia and subsequent carcinoma. The presence of gastric mucosal atrophy and intestinal metaplasia are important risk factors for GC. The purpose of this study was to investigate the incidence of GC attributed to atrophic gastritis in a region with high incidence of GC.
Eligibility Criteria
Inclusion Criteria: * Ability and willingness to participate in the study and to sign and give informed consent * Biopsies were collected based on the recommendation of updated Sydney system Exclusion Criteria: * under 18 or over 80 years old * history of gastrectomy * severe systemic diseases or malignancy
Frequently Asked Questions
Who can join the NCT06203327 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Atrophic Gastritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06203327 currently recruiting?
Yes, NCT06203327 is actively recruiting participants. Visit ClinicalTrials.gov or contact Shanghai Jiao Tong University School of Medicine to inquire about joining.
Where is the NCT06203327 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06203327 clinical trial?
NCT06203327 is sponsored by Shanghai Jiao Tong University School of Medicine. The trial plans to enroll 2,042 participants.